Stable liquid desoximethasone compositions with reduced oxidized impurity
AssigneeTaro Pharmaceutical North America, Inc.
InventorsSrinivasa Rao, Suresh Dixit, Avraham Yacobi, Arthur Bailey
Life of this patent
Estimating the term…
Loading patent…
AssigneeTaro Pharmaceutical North America, Inc.
InventorsSrinivasa Rao, Suresh Dixit, Avraham Yacobi, Arthur Bailey
Estimating the term…
The present invention relates to a stable liquid formulation comprising desoximetasone, isopropyl myristate, a C2-C4 alcohol and a stabilizing agent. Specifically, the present invention provides a liquid formulation comprising: a) about 0.01 wt % to about 2.5 wt % desoximetasone; b) about 10 wt % to about 70 wt % isopropyl myristate; c) about 20 wt % to about 70 wt % C2-C4 alcohol; and d) a stabilizing agent selected from the group consisting of an oleaginous vehicle and a propellant, wherein the stabilizing agent is in an amount sufficient to reduce the formation of less than about 1 wt % 17-carboxy-9α-fluoro-11β-hydroxy-16a-methyl-androsta-1,4-diene-3-one under an accelerated storage condition.
A liquid formulation comprising:
A process for preparing an aerosolized formulation of desoximetasone comprising the step of filling an aerosol formulation into a container equipped with a continuous valve, said aerosol formulation comprising:
Dependencies are inferred from the claim text.